Skip to main content
. 2021 Jan 7;42(2):479–489. doi: 10.1007/s10072-020-04946-w

Table 1.

Demographic data and prior medical history of COVID positive patients with mild, moderate, and severe encephalopathy, all encephalopathy cases, and cases without encephalopathy

Mild Moderate Severe Encephalopathy cases Cases without encephalopathy P value
Number of cases 12 18 13 43 12 -
Men 8 (67%) 12 (67%) 9 (69%) 29 (68%) 6 (50%) 0.17*
Age (years) 58.5 (+/− 15.9) 65.1 (+/− 12.9) 58.2 (+/− 15.8) 61.2 (+/− 14.7) 55.0 (+/− 9.8) 0.15*
Over 60 years of age 5 (33%) 11 (61%) 7 (54%) 22 (51%) 3 (25%) -
Days from initial respiratory symptoms to admission 7.0 (5.0–12.0) 2.5 (1.3–4.8) 5.0 (1.0–7.0) 3.5 (2.0–7.8) 6.5 (4.5–8.0) -
Days from admission to initial neurology consultation 4.0 (1.5–6.0) 10.0 (3.3–19.8) 6.0 (2.0–10.0) 5.0 (3.0–16.0) 11.5 (3.3–21.8) -
Prior medical history
  Hypertension 9 (75%) 14 (78%) 8 (62%) 31 (72%) 8 (67%) 0.61*
  Diabetes 6 (50%) 8 (44%) 5 (39%) 19 (44%) 4 (33%) 0.92*
  Heart disease 4 (33%) 2 (11%) 2 (15%) 8 (19%) 0 (0%) 0.68**
  Pulmonary disease 0 (0%) 2 (11%) 2 (15%) 5 (11%) 1 (8%) 0.52**
  Impaired renal function 3 (25%) 4 (22%) 4 (31%) 11 (26%) 3 (25%) 0.76**
  Alcohol abuse 2 (17%) 1 (6%) 1 (8%) 4 (9%) 0 (0%) 0.96**
  Smoking 1 (8%) 4 (22%) 5 (39%) 10 (23%) 2 (17%) 0.19**
  Cancer (in the previous 5 years) 0 (0%) 2 (11%) 3 (23%) 5 (12%) 2 (17%) 0.40**
  Immuno-suppressive drug use 1 (8%) 0 (0%) 3 (23%) 4 (9%) 3 (25%) 0.78**
  Prior neurologic disease 6 (50%) 5 (28%) 3 (23%) 14 (33%) 4 (33%) 0.33**
  Ischemic stroke 4 (33%) 3 (17%) 1 (8%) 8 (19%) 0 (0%) 0.97**
  Epilepsy 3 (25%) 0 (0%) 1 (8%) 4 (9%) 3 (25%) 0.06**
  Dementia 3 (25%) 1 (6%) 1 (8%) 5 (12%) 0 (0%) 0.93**

Data are median (interquartile range), mean (standard deviation) or n/N (%)

*Primary analysis, ordinal logistic regression

**Exploratory analysis, Mann-Whitney test